Imara Presents IMR-687 Phase 2a Open Label Extension Case Reports on Two Patients with Sickle Cell Disease at the 62nd ASH Annual Meeting and Exposition
7th December 2020
Portfolio
This post references, or is about Imara. Find out more by clicking below
Print Article
Email Article
Save Article
Stay Updated
Add your email below to stay updated with useful and informative content from Arix and our portfolio companies
